Last updated on July 2019

Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775])


Find a site near you

Start Over

Holy Name Medical Center

Teaneck, NJ United States
  Connect »

University of Rochester

Rochester, NY United States
  Connect »

Stephenson Cancer Center

Oklahoma City, OK United States
  Connect »

Sanford Gynecology Oncology

Sioux Falls, SD United States
  Connect »

UT West Cancer Center

Germantown, TN United States
  Connect »

Hospital Aleman

Buenos Aires, Argentina
  Connect »

Sanatorio Guemes

Buenos Aires, Argentina
  Connect »

Flinders Medical Centre

Bedford Park, Australia
  Connect »

St John of God

Subiaco, Australia
  Connect »

Oncomedica S.A.

Monteria, Colombia
  Connect »

National Cancer Center

Goyang-si, Korea, Republic of
  Connect »

Asan Medical Center

Seoul, Korea, Republic of
  Connect »

Samsung Medical Center

Seoul, Korea, Republic of
  Connect »

Leningrad Regional Oncology Center

Saint-Petersburg, Russian Federation
  Connect »

Addenbrookes Hospital

Cambridge, United Kingdom
  Connect »

Western General Hospital

Edinburgh, United Kingdom
  Connect »

Utah Cancer Specialists

Salt Lake City, UT United States
  Connect »